1. Home
  2. LINK vs ACET Comparison

LINK vs ACET Comparison

Compare LINK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

HOLD

Current Price

$4.31

Market Cap

81.4M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$4.87

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINK
ACET
Founded
1984
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
83.3M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
LINK
ACET
Price
$4.31
$4.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
N/A
★ $34.83
AVG Volume (30 Days)
45.1K
★ 297.1K
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.83
N/A
EPS
★ N/A
N/A
Revenue
★ $11,890,000.00
N/A
Revenue This Year
$40.45
N/A
Revenue Next Year
$19.16
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.81
N/A
52 Week Low
$2.66
$0.46
52 Week High
$10.34
$9.97

Technical Indicators

Market Signals
Indicator
LINK
ACET
Relative Strength Index (RSI) 30.01 25.48
Support Level $3.91 N/A
Resistance Level $5.10 $8.62
Average True Range (ATR) 0.39 0.61
MACD -0.16 -0.20
Stochastic Oscillator 3.96 1.91

Price Performance

Historical Comparison
LINK
ACET

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a provider of sensing technologies and printed electronics solutions that enable Human-Machine Interface (HMI) devices and Internet-of-Things (IoT) applications. Its broad product and technology portfolio spans force and touch sensors, piezoelectric sensors, rugged HMI sensors, wearable and textile-based sensors and electrochemical gas and environmental sensors, along with instruments and fully integrated systems based on its sensor technologies. It serves blue-chip customers and emerging companies across diverse end-use markets, including medical, industrial, automotive, consumer electronics, wearables, environmental monitoring, and specialty applications. It operates in single segment: the design, development, and manufacture of sensor technologies.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: